POS0926 REAL-WORLD EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYMYALGIA RHEUMATICAYuki Imai, Yoko Kaneko, Satoshi Takanashi|Annals of the Rheumatic Diseases|2024Cited by 2
SAT0093 CDAI AND DAS28 IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN CLINICAL PRACTICESatoshi Takanashi, Tsutomu Takeuchi, Yoko Kaneko|Annals of the Rheumatic Diseases|2020Cited by 1
FRI0462 Serum kl-6 is a strong predictor for relapse of myositis-associated interstitial lung diseaseSatoshi Takanashi, Tsutomu Takeuchi, Naoshi Nishina et al.|Annals of the Rheumatic Diseases|2018Cited by 0
AB1630 RISK FACTORS FOR CARDIAC INVOLVEMENT IN IDIOPATHIC INFLAMMATORY MYOPATHIESKatsuya Suzuki, Yoko Kaneko, Yasuhiko Kondo et al.|Annals of the Rheumatic Diseases|2023Cited by 0
POS0747 GENETIC POLYMORPHISMS IN METHOTREXATE METABOLISM: ASSOCIATIONS WITH METHOTREXATE POLYGLUTAMATES CONCENTRATIONS AND CLINICAL OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTSEri Yonezawa, Yoko Kaneko, Y. Sato et al.|Annals of the Rheumatic Diseases|2025Cited by 0